Literature DB >> 34542752

Analysis of the Specificity of Auto-Reactive Antibodies to Individual Fragments of the Extracellular Domain of Desmoglein 3 in Patients with Pemphigus Vulgaris.

A A Kubanov1, D G Deryabin2, M V Shpilevaya2, A E Karamova2, A A Nikonorov2, E N Larina3, T K Aliev4, D A Dolgikh3,4, T V Bobik3, I V Smirnov3, A G Gabibov3, M P Kirpichnikov3,4.   

Abstract

A method for the analysis of the epitope specificity of auto-reactive antibodies to desmoglein 3 (Dsg3) using competitive ELISA has been developed. It is based on a two-stage solid-phase ELISA with initial "depletion" of auto-reactive antibodies against the studied epitope and subsequent quantitative assessment of antibodies against full-length extracellular domain Dsg3. The proposed approach for assessing the specificity of the autoimmune response in patients with pemphigus vulgaris can provide in the future the possibility to personalize the therapy using plasmapheresis by preliminary selection of the antigenic composition of the extracorporeal immunosorbent.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ELISA; autoantibodies; autoimmunity; desmoglein 3; pemphigus vulgaris; specificity

Mesh:

Substances:

Year:  2021        PMID: 34542752     DOI: 10.1007/s10517-021-05254-9

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  11 in total

1.  Validation of chemiluminescent enzyme immunoassay in detection of autoantibodies in pemphigus and pemphigoid.

Authors:  Yumi Fujio; Kazuo Kojima; Masahiro Hashiguchi; Masatoshi Wakui; Mitsuru Murata; Masayuki Amagai; Jun Yamagami
Journal:  J Dermatol Sci       Date:  2016-12-06       Impact factor: 4.563

2.  IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris.

Authors:  Ralf Müller; Vera Svoboda; Elke Wenzel; Susanne Gebert; Nicolas Hunzelmann; Hans-Helge Müller; Michael Hertl
Journal:  Exp Dermatol       Date:  2006-08       Impact factor: 3.960

3.  Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.

Authors:  Enno Schmidt; Cornelia Dähnrich; Anke Rosemann; Christian Probst; Lars Komorowski; Sandra Saschenbrecker; Wolfgang Schlumberger; Winfried Stöcker; Takashi Hashimoto; Eva-Bettina Bröcker; Andreas Recke; Christian Rose; Detlef Zillikens
Journal:  Exp Dermatol       Date:  2010-02-16       Impact factor: 3.960

4.  Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic.

Authors:  M Amagai; S Karpati; R Prussick; V Klaus-Kovtun; J R Stanley
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

5.  Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus.

Authors:  M Amagai; T Hashimoto; N Shimizu; T Nishikawa
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

6.  Desmoglein ELISA in the diagnosis of pemphigus and its correlation with the severity of pemphigus vulgaris.

Authors:  Hossein Mortazavi; Majid Shahdi; Ali Akbar Amirzargar; Zahra S Naraghi; Mahin Valikhani; Maryam Daneshpazhooh; Amir Vasheghani-Farahani; Mojtaba Sedaghat; Cheyda Chams-Davatchi
Journal:  Iran J Allergy Asthma Immunol       Date:  2009-03       Impact factor: 1.464

7.  Suprabasal desmoglein 3 expression in the epidermis of transgenic mice results in hyperproliferation and abnormal differentiation.

Authors:  Anita J Merritt; Mohamed Y Berika; Wenwu Zhai; Sarah E Kirk; Baijing Ji; Matthew J Hardman; David R Garrod
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

8.  Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction.

Authors:  Wolfgang-Moritz Heupel; Detlef Zillikens; Detlev Drenckhahn; Jens Waschke
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

9.  Desmoglein isoform distribution affects stratum corneum structure and function.

Authors:  P M Elias; N Matsuyoshi; H Wu; C Lin; Z H Wang; B E Brown; J R Stanley
Journal:  J Cell Biol       Date:  2001-04-16       Impact factor: 10.539

Review 10.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.